ArticleCardiovascular toxicology2026
E-cigarette Aerosol Containing Nicotine Increases Aortic Stiffness in Young Mice.
Article in Cardiovascular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
E-cigarettes (E-cigs) are widely used especially among young people, but the effects on vascular stiffening and remodeling are poorly understood. This study evaluates the effects of short-term e-cig exposure on young vs. adult mice and the effects of e-cig derived chemicals present in plasma and urine of exposed animals on cultured endothelial cells (EC) and vascular smooth muscle cells (SMC). C57BL/6J mice of 6- and 14-weeks of age were exposed to unflavored e-cig aerosol with and without nicotine (50% propylene glycol, 50% vegetable glycerol +/- 24 mg/ml nicotine 3 weeks, puff duration of 9 s per minute, for 60 min/day) and aortic tissue subjected to in- and ex-vivo assessment of stiffness and histological evaluation. Major chemical constituents of e-cig aerosol were analyzed in plasma and urine samples, and cultured human aortic ECs and SMCs were treated with these chemicals, including acrolein, formaldehyde and nicotine. Changes in gene and protein expression were quantified, and functional ROS and MMP assays were performed. Pulse wave velocity revealed increased stiffness upon treatment with e-cig aerosol, and to a greater extent with the inclusion of nicotine (114% in 6-week-old and 112% in 14-week-old mice vs. baseline, p < 0.001), which was also observed in ex-vivo myography in aortic infrarenal and thoracic segments in 6-week-old mice after e-cig exposure. Aortic elastin content in these mice was decreased when compared to room-air controls (-24% in 6-week-old and - 36% in 14-week-old mice in thoracic aorta, p < 0.05). In vitro treatment with some of the different chemical compounds present in e-cig aerosol led to an increase in endothelial activation markers, and extracellular remodeling proteins. Wire myography showed an endothelium-independent decrease in relaxation in young murine aortas treated with nicotine. Our results indicate that short-term exposure over three weeks to e-cig aerosol leads to marked changes in murine aortic stiffness and vascular remodeling, potentially predisposing for cardiovascular disease conditions despite the superior remodeling capabilities of young animals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.